Prevalence of Gastroesophageal Reflux Disease in primary care patients with upper Gastrointestinal symptoms
Study identifier:NIS-GBG-NEX-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A cross-sectional study on the prevalence of GERD in primary care patients with upper GI symptoms using the GERD-Q. The Bulgarian GERD-Q Study
Medical condition
Gastroesophageal Reflux Disease
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
2210
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Nov 2009
Primary Completion Date: 01 Apr 2010
Study Completion Date: 01 Apr 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
